NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions, today ...

- Appointment completes build-out of Revance’s commercial leadership team following submission of the Company’s Biologics License Application to the U.S. Food and Drug Administration for ...

NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, today ...

Nashville-based aesthetics biotech company Revance Therapeutics has announced the expansion of its leadership team with appointments of three C-suite executives.